The Timken Company (TKR) said it is reducing full-year 2024 outlook, with earnings per share now forecasted to be in the range of $4.65 to $4.75 and adjusted earnings per share in the range of $5. ...

GAFFNEY — A Chinese-based company's plans for the former Timken Roller Bearing Plant in Gaffney include manufacturing lithium iron phosphate for use in batteries. The 600,000-square-foot ...

Timken Co. (Symbol: TKR) presently has an above average rank, in the top 50% of the coverage universe, which suggests it is among the top most "interesting" ideas that merit further research by ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Appian Capital Advisory last week scored a big win after the UK top court ruled that Sibanye-Stillwater (JSE: SSW) (NYSE: SBSW) had to pay the London-based investment firm compensation for the ...

Timken India Ltd share price was up by 1.02% from the previous closing price of ₹3,422.25. Who are peers of Timken India Ltd? The peers of Timken India Ltd are Schaeffler India Ltd, SKF India ...

JOHANNESBURG, Oct 14 (Reuters) - Sibanye Stillwater (SSWJ.J), opens new tab is facing a $522 million compensation claim from investment firm Appian Capital Advisory over the termination of a $1.2 ...

Simmons First National Corp (SFNC) capitalizes on market opportunities while navigating competitive deposit landscapes and modest loan growth. While the top- and bottom-line numbers for Simmons ...

As investors digest a flurry of earnings reports, stock futures are pointing to a lower open for major U.S. indexes, reflecting the ongoing volatility and mixed sentiment in the market. For those ...

DATA SOURCES: Corporate data, historical price & volume data published on this website have been sourced from CMOTS Internet Technologies Pvt. Ltd. BSE Quotes and NSE Quotes have been sourced from ...

Shares of Sun Pharmaceutical fell 2.64 per cent after the pharma major recently announced that the US District Court of delayed the launch of its new drug - Leqselvi. According to the stock ...